Brief: CSL Enters Agreements With U.S. Government To Lower Drug Prices
BRIEF-CSL Enters Agreements With U.S. Government To Lower Drug Prices Aug 31 (Reuters) - CSL:
CSL ENTERS AGREEMENTS WITH THE U.S. GOVERNMENT TO LOWER DRUG PRICES AND SUPPORT INVESTMENT IN U.S. MANUFACTURING
CSL LTD: AGREEMENTS SUPPORT LOWER PRICES FOR CSL THERAPIES AND REFLECT CSL'S $1.5 BILLION PLAN TO EXPAND ITS U.S. MANUFACTURING CAPACITY IN ILLINOIS
CSL : ENTERED INTO ONSHORING AGREEMENT WITH THE U.S. DEPARTMENT OF COMMERCE
CSL LTD: PROJECT IS EXPECTED TO CREATE AT LEAST 300 NEW PHARMACEUTICAL MANUFACTURING JOBS AND APPROXIMATELY 800 CONSTRUCTION AND RELATED JOBS
CSL : DOES NOT ANTICIPATE ANY MATERIAL IMPACT DURING FISCAL YEAR 2027
CSL : AGREEMENTS PROVIDE CSL WITH ADDITIONAL CERTAINTY REGARDING EXPOSURE TO U.S. DRUG PRICING & CERTAIN SECTION 232 TARIFFS
CSL : PROJECT TO SUBSTANTIALLY INCREASE CO'S ABILITY TO PRODUCE IMMUNOGLOBULINS & ALBUMIN FOR PEOPLE WITH RARE DISEASES & SERIOUS CONDITIONS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsCiti says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)
Brief: CSL Limited Appoints Deborah Waterhouse As CEO And Managing Director
Australia's CSL appoints Deborah Waterhouse as CEO
Early US flu season, current strain may signal risk for younger people; doctors urge shots